|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Item 9 Labs (OTCQX: INLB) through any online brokerage.
There are no as such competitors for Item 9 Labs.
The latest price target for Item 9 Labs (OTCQX: INLB) was reported by Noble Capital Markets on July 22, 2021. The analyst firm set a price target for 4.00 expecting INLB to rise to within 12 months (a possible 304.04% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Item 9 Labs (OTCQX: INLB) is $0.99 last updated Today at 5:42:08 PM.
There are no upcoming dividends for Item 9 Labs.
Item 9 Labs does not have any upcoming earnings scheduled.
There is no upcoming split for Item 9 Labs.
Item 9 Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQX.